This page is the continuation of reference in support of Section 1f.
REFERENCES
Bach PB, Mirkin JN, Oliver TK, et al. (2012). Benefits and harms of CT screening for lung cancer: a systematic review. JAMA 307(22), 2418–2429. (Retrieved 22nd Jan 2015): http://www.ncbi.nlm.nih.gov/pubmed/22610500
Berrington de González A, Darby S. (2004). Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries. Lancet. 363(9406), 345–351. (Retrieved 22nd Jan 2015): http://www.ncbi.nlm.nih.gov/pubmed/15070562
Brenner D, Doll R, Goodhead D, et al. (2003). Cancer risks attributable to low doses of ionizing radiation: assessing what we really know. Proc Natl Acad Sci U S A. 100(24), 1361– 6. (Retrieved 22nd Jan 2015): http://www.ncbi.nlm.nih.gov/pmc/articles/PMC283495/
Cody DD, Kim HJ, Cagnon CH, et al. (2010). Normalized CT dose index of the CT scanners used in the National Lung Screening Trial. AJR Am J Roentgenol. 194(6), 1539–46. (Retrieved 22nd Jan 2015): http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3015146/
Hall EJ, Brenner DJ. (2008). Cancer risks from diagnostic radiology. Br J Radiol. 81(965), 362–78. (Retrieved 22nd Jan 2015): http://www.ncbi.nlm.nih.gov/pubmed/18440940
Humphrey LL, Deffebach M, Pappas M, et al. (2013). Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation. Ann Intern Med 159(6), 411. (Retrieved 23rd Jan 2015): http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0058002/
Gareen IF, Duan F, Greco EM, et al. (2014). Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial. Cancer. 120(21), 3401-9. (Retrieved 23rd Jan 2015): http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4205265/
McCollough CH, Primak AN, Braun N, Kofler J, et al. (2014) Strategies for Reducing Radiation Dose in CT. Radiol Clin North Am. 2009 Jan; 47(1): 27–40. (Retrieved 1st April 2015): http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2743386/
Moynihan R, Doust J, Henry D.(2012). Preventing overdiagnosis: how to stop harming the healthy. BMJ 2012;344:e3502
(Retrieved 1st April 2015): https://www.researchgate.net/publication/225074295_Preventing_overdiagnosis_How_to_stop_harming_the_healthy
Moyer VA. (2014). Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 160(5), 330–8. (Retrieved 22nd Jan 2015): http://annals.org/article.aspx?articleid=1809422
O’Connor GT, Hatabu H. (2012). Lung cancer screening, radiation, risks, benefits, and uncertainty. JAMA. 307, 2434–5. (Retrieved 22nd Jan 2015): http://jama.jamanetwork.com/article.aspx?articleid=1182842
Patz EF, Pinsky P, Gatsonis C, Sicks JD, Kramer BS, Tammemägi MC, et al. (2014). Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med. Feb 1;174(2):269-74 (Retrieved 1st April 2015): http://www.ncbi.nlm.nih.gov/pubmed/24322569
U.S. Preventive Services Task Force. (2004). Lung cancer screening: recommendation statement. Ann Intern Med. 140(9), 738–9. (Retrieved 22nd Jan 2015): http://annals.org/article.aspx?articleid=717423
Wood DE, Eapen GA, Ettinger DS, et al. (2012). Lung cancer screening. Journal of the National Comprehensive Cancer Network 10(2), 240–265. (Retrieved 22nd Jan 2015): http://www.ncbi.nlm.nih.gov/pubmed/22308518
